Darzalex (daratumumab) 1,800 mg, Janssen Darzalex is used with bortezomib, melphalan and prednisone for certain adults with newly diagnosed multiple myeloma. Contact +380996042415.
Delivery methods
- Delivery of non-temperature-controlled medicines to Chisinau - $25.
Delivery of temperature-controlled medicines to Chisinau - $50.
Up to 5 packages can be sent per shipment. The price applies to one shipment. - Pickup from Odesafree
- Shipping within Ukraine by Nova Poshta at the carrier's rates.
Payment in UAH upon receipt of the order.
Delivery time
- Originator medicines: 5-7 days
- Generic medicines: 3-4 days
Payment methods
- Bank transfer to the settlement account after receiving the order
- Payment upon pickup in Odesa
Darzalex® is prescribed:
in combination with bortezomib, melphalan and prednisone for the treatment of adult patients with newly diagnosed multiple myeloma who are not candidates for autologous stem cell transplantation;
as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma whose prior therapy included a proteasome inhibitor and an immunomodulatory agent and who had disease progression during the last therapy;
as part of combination therapy with lenalidomide and dexamethasone or bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one line of therapy.
- Trade name:Darzalex
- Chemical name:Daratumumab
- Dosage:1800
- Quantity:1
- Dosage form:Vial
No reviews yet
